These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2175557

  • 1. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.
    Chapman HA, Bertozzi P, Sailor LZ, Nusrat AR.
    Am J Physiol; 1990 Dec; 259(6 Pt 1):L432-8. PubMed ID: 2175557
    [Abstract] [Full Text] [Related]

  • 2. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Cubellis MV, Andreasen P, Ragno P, Mayer M, Danø K, Blasi F.
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
    [Abstract] [Full Text] [Related]

  • 3. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 4. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P, Montuori N, Rossi G.
    Eur J Biochem; 1995 Oct 15; 233(2):514-9. PubMed ID: 7588796
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    Estreicher A, Wohlwend A, Belin D, Schleuning WD, Vassalli JD.
    J Biol Chem; 1989 Jan 15; 264(2):1180-9. PubMed ID: 2536017
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
    Ellis V, Wun TC, Behrendt N, Rønne E, Danø K.
    J Biol Chem; 1990 Jun 15; 265(17):9904-8. PubMed ID: 2161846
    [Abstract] [Full Text] [Related]

  • 7. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.
    Cubellis MV, Wun TC, Blasi F.
    EMBO J; 1990 Apr 15; 9(4):1079-85. PubMed ID: 2157592
    [Abstract] [Full Text] [Related]

  • 8. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep 15; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 9. Processing of complex between urokinase and its type-2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity.
    Ragno P, Montuori N, Vassalli JD, Rossi G.
    FEBS Lett; 1993 Jun 01; 323(3):279-84. PubMed ID: 8388810
    [Abstract] [Full Text] [Related]

  • 10. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ, McCaffrey TA, Mathew J, McAdam K, Borth W.
    J Cell Physiol; 1995 Aug 01; 164(2):334-43. PubMed ID: 7622580
    [Abstract] [Full Text] [Related]

  • 11. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA, Hamel NM.
    J Biol Chem; 1990 Feb 15; 265(5):2908-16. PubMed ID: 2154465
    [Abstract] [Full Text] [Related]

  • 12. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES, Kuo A, Rosenfeld L, Karikó K, Leski M, Robbiati F, Nolli ML, Henkin J, Cines DB.
    J Biol Chem; 1990 Feb 15; 265(5):2865-72. PubMed ID: 2154462
    [Abstract] [Full Text] [Related]

  • 13. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
    McNeill H, Jensen PJ.
    Cell Regul; 1990 Oct 15; 1(11):843-52. PubMed ID: 1965151
    [Abstract] [Full Text] [Related]

  • 14. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N, List K, Andreasen PA, Danø K.
    Biochem J; 2003 Apr 15; 371(Pt 2):277-87. PubMed ID: 12534347
    [Abstract] [Full Text] [Related]

  • 15. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    Estreicher A, Mühlhauser J, Carpentier JL, Orci L, Vassalli JD.
    J Cell Biol; 1990 Aug 15; 111(2):783-92. PubMed ID: 2166055
    [Abstract] [Full Text] [Related]

  • 16. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA, Stone OL, Vavrin Z.
    J Clin Invest; 1984 Mar 15; 73(3):806-15. PubMed ID: 6368589
    [Abstract] [Full Text] [Related]

  • 17. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT.
    Thromb Haemost; 1997 Mar 15; 77(3):540-7. PubMed ID: 9066008
    [Abstract] [Full Text] [Related]

  • 18. Autocrine saturation of pro-urokinase receptors on human A431 cells.
    Stoppelli MP, Tacchetti C, Cubellis MV, Corti A, Hearing VJ, Cassani G, Appella E, Blasi F.
    Cell; 1986 Jun 06; 45(5):675-84. PubMed ID: 3011276
    [Abstract] [Full Text] [Related]

  • 19. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
    Mignatti P, Mazzieri R, Rifkin DB.
    J Cell Biol; 1991 Jun 06; 113(5):1193-201. PubMed ID: 1645739
    [Abstract] [Full Text] [Related]

  • 20. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H.
    J Urol; 2005 Aug 06; 174(2):461-5. PubMed ID: 16006865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.